Meg Samek-Smith, MultiplAI Health - RNA-Based, AI-Driven Screening Technology | LSI USA '24

MultiplAI Health is developing an RNA-based, AI-driven screening technology to transform the way cardiovascular disease is screened and diagnosed.

LSI Europe ‘24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders.

September 16-20, 2024 The Ritz-Carlton - Sintra, Portugal Register arrow
lsi logo
Customer Login Contact

Events

Market Intelligence

Explore Media

17011 Beach Blvd, Suite 500
Huntington Beach, CA 92647

714-847-3540

© 2024 Life Science Intelligence, Inc., All Rights Reserved.